Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now early-phase tilt small index

Osteogenesis Imperfecta (OI): early-phase trial registry

1 of 1 indexed Osteogenesis Imperfecta (OI) trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · 1 currently recruiting · #11,370 of 28,707 conditions by registered trial count

Osteogenesis Imperfecta (OI): 1 US clinical trial tracked, 1 recruiting.

Osteogenesis Imperfecta (OI) is the subject of 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Angitia Incorporated Limited, running 1 of these trials.

Enrollment posture brief

Registry condition osteogenesis-imperfecta-oi

OPEN 1 | RECR 100% | LATE 0 | EARLY 1 | RANK #11370 | SPON 1

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Osteogenesis Imperfecta (thi…100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Osteogenesis Imperfecta (OI)

Osteogenesis Imperfecta (OI) lists 1 open slots (100% of 1 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Osteogenesis Imperfecta (OI) on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Osteogenesis Imperfecta (OI) is recruiting above its size-band peers.

    1 of 1 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 21

Phase Distribution

PhaseTrial count
Phase 2 1

Top Sponsors

Named interventions

Most-linked intervention names on Osteogenesis Imperfecta (OI) records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

AGA2115 Drug
1 trials
Placebo Other
1 trials

US sites by state

Facility locations filed on Osteogenesis Imperfecta (OI) trials. A trial with sites in several states counts in each.

Tennessee 1 trials
Oregon 1 trials
Ohio 1 trials
New Mexico 1 trials
Nebraska 1 trials
Missouri 1 trials
Indiana 1 trials
Delaware 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Osteogenesis Imperfecta (OI) page

1 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Osteogenesis Imperfecta (OI) condition card totals 1 registered trials; most-linked intervention AGA2115; top US site state Tennessee. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.